<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04122222</url>
  </required_header>
  <id_info>
    <org_study_id>07-59-14</org_study_id>
    <nct_id>NCT04122222</nct_id>
  </id_info>
  <brief_title>Immune Response to Influenza Vaccine in ESRD Patients</brief_title>
  <official_title>Immune Response to Influenza Vaccination in ESRD Patients Undergoing Hemodialysis vs. Hemodiafiltration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bhumirajanagarindra Kidney Institute, Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      On-line hemodiafiltration (HDF) clears more azotaemic toxins compared to high-flux
      hemodialysis (HD). The response to vaccination is impaired in dialysis patients. We aimed to
      study the immune responses to influenza vaccine in dialysis patients treated by HDF vs. HD.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 25, 2016</start_date>
  <completion_date type="Actual">July 20, 2018</completion_date>
  <primary_completion_date type="Actual">July 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A prospective cohort study in chronic dialysis patients during the 2016 and 2017 influenza seasons
All participants received a single standard dose of trivalent influenza vaccine
The elicited humoral immune response by hemagglutination inhibition test, and cell-mediated immune response by enumeration of lymphocyte cellular markers and proliferation assays are studied.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>measurement antibody titers, determined by hemagglutination inhibition (HI) assay.</measure>
    <time_frame>12 months</time_frame>
    <description>measurement antibody titers, determined by hemagglutination inhibition (HI) assay.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>measurement T cell subpopulations, determined by flow cytometer AND cell proliferation assay after stimulated with influenza viruses.</measure>
    <time_frame>12 months</time_frame>
    <description>measurement T cell subpopulations, determined by flow cytometer AND cell proliferation assay after stimulated with influenza viruses.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Immunology</condition>
  <condition>Nephrology</condition>
  <arm_group>
    <arm_group_label>Hemodialysis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ESRD patients treated by hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hemodiafiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ESRD patients treated by on-line hemodiafiltration</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Influenza vaccine</intervention_name>
    <description>A single standard dose of inactivated trivalent influenza vaccine: Influvac® vaccines (Abbott, the Netherlands), intramuscularly.</description>
    <arm_group_label>Hemodiafiltration</arm_group_label>
    <arm_group_label>Hemodialysis</arm_group_label>
    <other_name>A single standard dose of inactivated trivalent influenza vaccine: Influvac® vaccines (Abbott, the Netherlands), intramuscularly.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - ESRD patients aged 18 years or older, who had been treated for more than one month of
        either thrice weekly on-line hemodiafiltration (HDF) or conventional high flux hemodialysis
        (HD), with a session dialyzer urea clearance (Kt/V urea) of 1.2 and greater, with a
        convection volume target of 20 L/session for the HDF group

        Exclusion Criteria:

          -  Had received any vaccination within the previous four weeks, or influenza vaccination
             within six months

          -  Patient who reported upper respiratory tract symptoms within three days prior to the
             study vaccination

          -  A history of allergy to influenza vaccine or egg

          -  Thrombocytopenia

          -  In receipt of immunosuppressant medications, chemotherapy, or had immunodeficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Descamps-Latscha B. The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens. 1993 Nov;2(6):883-91. Review.</citation>
    <PMID>7922228</PMID>
  </results_reference>
  <results_reference>
    <citation>Hauser AB, Stinghen AE, Kato S, Bucharles S, Aita C, Yuzawa Y, Pecoits-Filho R. Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int. 2008 Jun;28 Suppl 3:S183-7. Review.</citation>
    <PMID>18552253</PMID>
  </results_reference>
  <results_reference>
    <citation>Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008 Sep;3(5):1526-33. doi: 10.2215/CJN.00950208. Epub 2008 Aug 13. Review.</citation>
    <PMID>18701615</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen G, Hörl WH. Immune dysfunction in uremia&amp;#8212;an update. Toxins (Basel). 2012 Oct 24;4(11):962-90. doi: 10.3390/toxins4110962. Review.</citation>
    <PMID>23202302</PMID>
  </results_reference>
  <results_reference>
    <citation>Girndt M, Sester M, Sester U, Kaul H, Köhler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl. 2001 Feb;78:S206-11. Review.</citation>
    <PMID>11169012</PMID>
  </results_reference>
  <results_reference>
    <citation>Meijers RW, Litjens NH, de Wit EA, Langerak AW, van der Spek A, Baan CC, Weimar W, Betjes MG. Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients. Immun Ageing. 2012 Sep 12;9(1):19. doi: 10.1186/1742-4933-9-19.</citation>
    <PMID>22971545</PMID>
  </results_reference>
  <results_reference>
    <citation>Anding K, Gross P, Rost JM, Allgaier D, Jacobs E. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant. 2003 Oct;18(10):2067-73.</citation>
    <PMID>13679482</PMID>
  </results_reference>
  <results_reference>
    <citation>Lim WH, Kireta S, Leedham E, Russ GR, Coates PT. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int. 2007 Nov;72(9):1138-48. Epub 2007 Aug 29.</citation>
    <PMID>17728708</PMID>
  </results_reference>
  <results_reference>
    <citation>Sester U, Sester M, Hauk M, Kaul H, Köhler H, Girndt M. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant. 2000 Aug;15(8):1217-23.</citation>
    <PMID>10910448</PMID>
  </results_reference>
  <results_reference>
    <citation>Fernández-Fresnedo G, Ramos MA, González-Pardo MC, de Francisco AL, López-Hoyos M, Arias M. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant. 2000 Apr;15(4):502-10.</citation>
    <PMID>10727545</PMID>
  </results_reference>
  <results_reference>
    <citation>Chou CY, Wang SM, Liang CC, Chang CT, Liu JH, Wang IK, Hsiao LC, Muo CH, Huang CC, Wang RY. Risk of pneumonia among patients with chronic kidney disease in outpatient and inpatient settings: a nationwide population-based study. Medicine (Baltimore). 2014 Dec;93(27):e174. doi: 10.1097/MD.0000000000000174.</citation>
    <PMID>25501062</PMID>
  </results_reference>
  <results_reference>
    <citation>Collins AJ, Foley RN, Gilbertson DT, Chen SC. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S5-11. doi: 10.2215/CJN.05980809. Review.</citation>
    <PMID>19996006</PMID>
  </results_reference>
  <results_reference>
    <citation>Viasus D, Garcia-Vidal C, Cruzado JM, Adamuz J, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease. Nephrol Dial Transplant. 2011 Sep;26(9):2899-906. doi: 10.1093/ndt/gfq798. Epub 2011 Jan 27.</citation>
    <PMID>21273232</PMID>
  </results_reference>
  <results_reference>
    <citation>Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001 Dec;120(6):1883-7.</citation>
    <PMID>11742917</PMID>
  </results_reference>
  <results_reference>
    <citation>Nordio M, Limido A, Maggiore U, Nichelatti M, Postorino M, Quintaliani G; Italian Dialysis and Transplantation Registry. Survival in patients treated by long-term dialysis compared with the general population. Am J Kidney Dis. 2012 Jun;59(6):819-28. doi: 10.1053/j.ajkd.2011.12.023. Epub 2012 Feb 22.</citation>
    <PMID>22361043</PMID>
  </results_reference>
  <results_reference>
    <citation>Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ; HEMO Study Group. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol. 2003 Jul;14(7):1863-70.</citation>
    <PMID>12819247</PMID>
  </results_reference>
  <results_reference>
    <citation>Carracedo J, Merino A, Nogueras S, Carretero D, Berdud I, Ramírez R, Tetta C, Rodríguez M, Martín-Malo A, Aljama P. On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: A prospective, crossover study. J Am Soc Nephrol. 2006 Aug;17(8):2315-21. Epub 2006 Jul 6.</citation>
    <PMID>16825330</PMID>
  </results_reference>
  <results_reference>
    <citation>den Hoedt CH, Grooteman MP, Bots ML, Blankestijn PJ, van der Tweel I, van der Weerd NC, Penne EL, Mazairac AH, Levesque R, ter Wee PM, Nubé MJ, van den Dorpel MA; CONTRAST investigators. The Effect of Online Hemodiafiltration on Infections: Results from the CONvective TRAnsport STudy. PLoS One. 2015 Aug 19;10(8):e0135908. doi: 10.1371/journal.pone.0135908. eCollection 2015.</citation>
    <PMID>26288091</PMID>
  </results_reference>
  <results_reference>
    <citation>DaRoza G, Loewen A, Djurdjev O, Love J, Kempston C, Burnett S, Kiaii M, Taylor PA, Levin A. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis. 2003 Dec;42(6):1184-92.</citation>
    <PMID>14655190</PMID>
  </results_reference>
  <results_reference>
    <citation>Dede F, Yıldız A, Aylı D, Colak N, Odabaş AR, Akoğlu H, Eskioğlu E, Covic A. Modulation of the immune response to HBV vaccination by hemodialysis membranes. Int Urol Nephrol. 2010 Dec;42(4):1069-75. doi: 10.1007/s11255-009-9616-z. Epub 2009 Jul 19.</citation>
    <PMID>19618288</PMID>
  </results_reference>
  <results_reference>
    <citation>den Hoedt CH, Bots ML, Grooteman MP, van der Weerd NC, Mazairac AH, Penne EL, Levesque R, ter Wee PM, Nubé MJ, Blankestijn PJ, van den Dorpel MA; CONTRAST Investigators. Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis. Kidney Int. 2014 Aug;86(2):423-32. doi: 10.1038/ki.2014.9. Epub 2014 Feb 19.</citation>
    <PMID>24552852</PMID>
  </results_reference>
  <results_reference>
    <citation>Rama I, Llaudó I, Fontova P, Cerezo G, Soto C, Javierre C, Hueso M, Montero N, Martínez-Castelao A, Torras J, Grinyó JM, Cruzado JM, Lloberas N. Online Haemodiafiltration Improves Inflammatory State in Dialysis Patients: A Longitudinal Study. PLoS One. 2016 Oct 26;11(10):e0164969. doi: 10.1371/journal.pone.0164969. eCollection 2016.</citation>
    <PMID>27783636</PMID>
  </results_reference>
  <results_reference>
    <citation>Eiselt J, Kielberger L, Rajdl D, Racek J, Pazdiora P, Malánová L. Previous Vaccination and Age are More Important Predictors of Immune Response to Influenza Vaccine than Inflammation and Iron Status in Dialysis Patients. Kidney Blood Press Res. 2016;41(2):139-47. doi: 10.1159/000443416. Epub 2016 Feb 26.</citation>
    <PMID>26914585</PMID>
  </results_reference>
  <results_reference>
    <citation>Young B, Zhao X, Cook AR, Parry CM, Wilder-Smith A, I-Cheng MC. Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis. Vaccine. 2017 Jan 5;35(2):212-221. doi: 10.1016/j.vaccine.2016.11.013. Epub 2016 Dec 7. Review.</citation>
    <PMID>27939013</PMID>
  </results_reference>
  <results_reference>
    <citation>Betjes MG, Langerak AW, van der Spek A, de Wit EA, Litjens NH. Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int. 2011 Jul;80(2):208-17. doi: 10.1038/ki.2011.110. Epub 2011 Apr 27.</citation>
    <PMID>21525849</PMID>
  </results_reference>
  <results_reference>
    <citation>Crespo M, Collado S, Mir M, Cao H, Barbosa F, Serra C, Hidalgo C, Faura A, Montero M, García de Lomas J, Horcajada JP, Puig JM, Pascual J. Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol. 2011 Sep;6(9):2208-14. doi: 10.2215/CJN.02160311. Epub 2011 Aug 18.</citation>
    <PMID>21852661</PMID>
  </results_reference>
  <results_reference>
    <citation>Ausiello CM, la Sala A, Ramoni C, Urbani F, Funaro A, Malavasi F. Secretion of IFN-gamma, IL-6, granulocyte-macrophage colony-stimulating factor and IL-10 cytokines after activation of human purified T lymphocytes upon CD38 ligation. Cell Immunol. 1996 Nov 1;173(2):192-7.</citation>
    <PMID>8912876</PMID>
  </results_reference>
  <results_reference>
    <citation>Zupo S, Rugari E, Dono M, Taborelli G, Malavasi F, Ferrarini M. CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells. Eur J Immunol. 1994 May;24(5):1218-22.</citation>
    <PMID>8181532</PMID>
  </results_reference>
  <results_reference>
    <citation>Moro-García MA, Alonso-Arias R, López-Larrea C. When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes. Front Immunol. 2013 May 10;4:107. doi: 10.3389/fimmu.2013.00107. eCollection 2013.</citation>
    <PMID>23675374</PMID>
  </results_reference>
  <results_reference>
    <citation>Xiaoyan J, Rongyi C, Xuesen C, Jianzhou Z, Jun J, Xiaoqiang D, Xiaofang Y. The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality. BMC Nephrol. 2019 Aug 5;20(1):301. doi: 10.1186/s12882-019-1475-y.</citation>
    <PMID>31383007</PMID>
  </results_reference>
  <results_reference>
    <citation>Ducloux D, Legendre M, Bamoulid J, Rebibou JM, Saas P, Courivaud C, Crepin T. ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications. Immun Ageing. 2018 Jul 17;15:16. doi: 10.1186/s12979-018-0121-z. eCollection 2018.</citation>
    <PMID>30026783</PMID>
  </results_reference>
  <results_reference>
    <citation>Valkenburg SA, Li OTW, Li A, Bull M, Waldmann TA, Perera LP, Peiris M, Poon LLM. Protection by universal influenza vaccine is mediated by memory CD4 T cells. Vaccine. 2018 Jul 5;36(29):4198-4206. doi: 10.1016/j.vaccine.2018.06.007. Epub 2018 Jun 7.</citation>
    <PMID>29887326</PMID>
  </results_reference>
  <results_reference>
    <citation>Co MD, Orphin L, Cruz J, Pazoles P, Rothman AL, Ennis FA, Terajima M. Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine. Vaccine. 2008 Apr 7;26(16):1990-8. doi: 10.1016/j.vaccine.2008.02.024. Epub 2008 Feb 26.</citation>
    <PMID>18339461</PMID>
  </results_reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 3, 2019</study_first_submitted>
  <study_first_submitted_qc>October 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2019</study_first_posted>
  <last_update_submitted>October 8, 2019</last_update_submitted>
  <last_update_submitted_qc>October 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Arkom Nongnuch</investigator_full_name>
    <investigator_title>Assist. Prof</investigator_title>
  </responsible_party>
  <keyword>ESRD</keyword>
  <keyword>hemodialysis</keyword>
  <keyword>hemodiafiltration</keyword>
  <keyword>influenza vaccine</keyword>
  <keyword>immune response</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>International journal involving immunology and/or nephrology</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>6 months</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

